Three-year follow-up of anthracycline-induced cardiotoxicity risk in breast cancer patients using the HFA-ICOS score

20 June 2025 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Who is at risk of cardiovascular toxicity? Stratification, Prevention and Monitoring CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

ESC 365 is supported by

ESC 365 is supported by